13. Based on the passage, it can be concluded that

Answer: A

Explanation:

Advances in technology, such as the hybrid, closed loop system, don't replace the need for a cure.

The passage emphasizes that while significant advancements in diabetes management technology, including hybrid closed-loop systems, have improved the quality of life for individuals with type 1 diabetes (T1D), they do not eliminate the necessity for a cure. Researchers continue to strive for a cure, indicating that these advancements are supportive but not a replacement for a definitive solution.

A) advances in technology, such as the hybrid, closed loop system, don't replace the need for a cure.

This option is correct as the extract clearly states that while these technologies enhance the management of T1D, a cure remains a goal for researchers. It highlights that improvements in management do not fulfill the ultimate need for a cure.

B) patients with T1D who use hybrid closed-loop systems will have the same lifespan as those without T1D.

This option is incorrect because the passage does not provide evidence or data suggesting that the lifespan of patients with T1D using hybrid closed-loop systems would equal that of individuals without T1D. The focus is on management, not lifespan equivalence.

C) hybrid closed-loop systems will not be widely used in the future.

This option is also incorrect as the passage discusses the FDA's approval of these systems and their current commercial availability, suggesting they are likely to be adopted widely rather than facing obsolescence.

D) new technology allows people with T1D to no longer have to monitor their condition.

This option is incorrect because the passage explicitly states that monitoring remains an essential part of disease management, even with the introduction of new technologies. Patients still need to manage their insulin intake and blood sugar levels actively.

Conclusion

In summary, option A accurately reflects the content of the passage regarding the advancements in diabetes technology and the ongoing need for a cure for T1D. The other options misinterpret or misrepresent the implications of the advancements discussed in the extract, reinforcing that while technology is beneficial, it does not substitute for a permanent solution.